Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 319
Selected: 0
NCT IDTitle
NCT03486496Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation
NCT07405346A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy
NCT03244774Phase I Study of the Combination of Apatinib and POF
NCT03788174Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma
NCT03846726Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response
NCT07469306Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
NCT05001971Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
NCT04533243Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
NCT02448953Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement
NCT07618078RAIRI-Guided Adjuvant Therapy Benefit in Nasopharyngeal Cancer
NCT07088484Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma
NCT03666221Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
NCT06462313Dobutamine for Management of Surgical Patients With Septic Shock
NCT03185429TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor
NCT02560441Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
NCT05730595Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
NCT03137004Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer
NCT06417476Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
NCT07492654Clinical Study on the Prevention and Treatment of Radiation Vaginitis With Triethanolamine Cream
NCT02971345Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
NCT07070713Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
NCT05266820Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer
NCT05595889Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
NCT07188584Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
NCT02886195EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC
NCT06957938Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
NCT06101966A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
NCT06260553Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC
NCT05824312HRQOL in Locally Advanced Thyroid Carcinoma
NCT06455072Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
NCT07240753A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma
NCT06743867The Safety and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Metastatic Adenocarcinoma
NCT06713421Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT06786312A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT04711434PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
NCT07306481The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer
NCT05461664Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
NCT05007145PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
NCT07310771Sintilimab-Nimotuzumab Induction Followed by Chemoradiation-Nimotuzumab in LA-HNSCC: Single-Arm Phase II
NCT03308552Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
NCT03566576Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
NCT06572293Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma
NCT07252375A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma
NCT04220528Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC
NCT04129710A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
NCT06136962Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT03468712Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
NCT05519956Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines
NCT05648994TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors